The acute spinal cord injury therapeutics market expected to register slow growth, and has been forecast to grow at a compound annual growth rate (CAGR) of approximately 1% to 2019, growing from a market value of £6 million in 2011, to be worth $6.5 million in 2019.
Spinal cord injury refers to damage to the spinal cord which results in the loss of mobility and feeling. The classification of spinal cord injury into acute and chronic phases is based on the period of time the patient has suffered with the condition.
The absence of effective treatment options within the acute spinal cord injury therapeutics market clearly signifies that current competition in the market is weak.
Therefore, significant opportunity exists for novel products that can provide better treatment, and offer better recovery from injury.
The acute spinal cord injury therapeutics market is expected to record sluggish growth due to the lack of approved therapies, the early stages of all molecules in clinical development, and the indication by Key Opinion Leaders that the incidence of acute spinal cord injury cases has remained stable in the immediate past, with this trend likely to continue in the market into the near future.
It has been predicted that there are currently 14 molecules in the pipeline, all of which are first-in-class. These new inventions aim to protect surviving nerve cells from additional damage, and stimulate the re-growth and connection of axons, showing strong potential to offer better options for the treatment of acute spinal cord injury than those available at present.
For more information on the acute spinal cord injury therapeutics market, see the latest research: Acute Spinal Cord Injury Therapeutics Market Report
Follow us on Twitter @CandMResearch
Companiesandmarkets.com issues news updates and report summaries covering all major industries and sectors. The service provides additional client monitoring and timely alerts to breaking industry and sector news leading the day's business headlines. News articles, written by our staff, contain additional analyst insight, providing value added insight for our readers. News updates and real-time alerts on newly-released market reports are also available from our Facebook page, Twitter feed @CandMResearch and RSS links. We also welcome inquiries from business journalists and the news media.